MARKET

ADAG

ADAG

Adagene Inc.
NASDAQ
1.900
+0.070
+3.83%
After Hours: 1.740 -0.16 -8.42% 18:52 07/15 EDT
OPEN
1.920
PREV CLOSE
1.830
HIGH
1.920
LOW
1.720
VOLUME
914.29K
TURNOVER
--
52 WEEK HIGH
3.581
52 WEEK LOW
1.325
MARKET CAP
89.51M
P/E (TTM)
-2.5596
1D
5D
1M
3M
1Y
5Y
1D
Adagene Advances Clinical Plan for ADG126 in Colorectal Cancer After FDA Meeting
TipRanks · 15h ago
Adagene announces regulatory update on development plan for muzastotug
TipRanks · 15h ago
Weekly Report: what happened at ADAG last week (0707-0711)?
Weekly Report · 1d ago
Adagene and ConjugateBio partner to develop antibody drug conjugate
TipRanks · 07/08 11:10
Weekly Report: what happened at ADAG last week (0630-0704)?
Weekly Report · 07/07 11:34
Adagene Secures $25 Million Investment from Sanofi to Advance Cancer Therapies
TipRanks · 07/01 13:12
Adagene Announces Upto $25 Mln Investment From Sanofi, Stock Up In Pre-Market
NASDAQ · 07/01 12:11
Adagene gains as Sanofi collaboration expands
Seeking Alpha · 07/01 11:31
More
About ADAG
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. The Company is principally engaged in the research, development and production of monoclonal antibody drugs for cancers. The Company’s main products include: ADG106 is being developed for the treatment of advanced solid tumors and non-Hodgkin's lymphoma, or NHL. ADG126 is designed to address the toxicity and efficacy issues related to the MOA of existing approved CTLA-4 immuno-oncology therapies and to expand the potential of CTLA-4 as a target for the treatment of cancer. ADG116 is designed to target a unique conserved epitope of CTLA-4. And ADG104, a monospecific antibody that targets PD-L1 and is in Phase Ib and Phase II clinical trials concurrently in China.

Webull offers Adagene Inc (ADR) stock information, including NASDAQ: ADAG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADAG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADAG stock methods without spending real money on the virtual paper trading platform.